Aizen Enters into Collaboration with San Diego Biopharma to Advance Oral Biologics Share Post Post navigation Previous PostKleiman Rajaram and Phillips & Cohen Announce Successful $46 Million Qui Tam Action Against Veloxis PharmaceuticalsNext Post CATL and Quinbrook Build on Supernode Partnership Following Stage 2 and Stage 3 Major Milestones